In 2019, the Swiss pharmaceutical company Novartis AG’s total revenue amounted to just over 47 billion U.S. dollars. This is a decrease of some four billion U.S. dollars compared to the year before.
Novartis’ revenue by segment
Between 2014 and 2019, the multinational corporation, based in Basel, Switzerland, generated the bulk of its revenue through pharmaceuticals (innovative medicines): in 2019, the company made 38.5 billion U.S. dollars from this segment. That year Novartis generated close to 20 percent of its revenue from its generic drug division (Sandoz).
Competitor Sanofi
Another global leader in the world of healthcare and pharmaceuticals is Sanofi, which is based in Paris, France. In 2018, the French company generated about 34.5 billion euros' worth of revenue. That same year, the majority of Sanofi’s revenue was earned through pharmaceuticals (roughly 24.6 billion euros), while the vaccine business segment generated just over 5.1 billion.
Novartis AG's total revenue from 2007 to 2019
(in billion U.S. dollars)
This statistic was assembled from several editions of Novartis' annual report.
* With the 2015 Annual Report, values back to 2011 were restated, as a result of a series of transactions during 2015.
** During this year, eye care division Alcon was spun off and became an own company. Thus, Alcon's revenues are not included.
Profit from additional features by authenticating your Admin account
Please authenticate by going to "My account" → "Administration".
Then you will be able to mark statistics as favourites and use personal statistics alerts.
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
Statista Accounts:
Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Single Account
Your perfect start with Statista
Instant access to 1m statistics
Download in XLS, PDF & PNG format
Detailed references
$59 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract; Prices do not include sales tax.
Statista Accounts:
Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.
Novartis. (January 29, 2020). Novartis AG's total revenue from 2007 to 2019 (in billion U.S. dollars) [Graph]. In Statista. Retrieved July 13, 2020, from https://www.statista.com/statistics/264238/novartis-revenues-since-2007/
Novartis. "Novartis AG's total revenue from 2007 to 2019 (in billion U.S. dollars)." Chart. January 29, 2020. Statista. Accessed July 13, 2020. https://www.statista.com/statistics/264238/novartis-revenues-since-2007/
Novartis. (2020). Novartis AG's total revenue from 2007 to 2019 (in billion U.S. dollars). Statista. Statista Inc.. Accessed: July 13, 2020. https://www.statista.com/statistics/264238/novartis-revenues-since-2007/
Novartis. "Novartis Ag's Total Revenue from 2007 to 2019 (in Billion U.S. Dollars)." Statista, Statista Inc., 29 Jan 2020, https://www.statista.com/statistics/264238/novartis-revenues-since-2007/
Novartis, Novartis AG's total revenue from 2007 to 2019 (in billion U.S. dollars) Statista, https://www.statista.com/statistics/264238/novartis-revenues-since-2007/ (last visited July 13, 2020)
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.
